Uniqure NV (NASDAQ:QURE)

18.06
Delayed Data
As of Jan 21
 -0.20 / -1.10%
Today’s Change
18.03
Today|||52-Week Range
40.49
-12.92%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$933.7M

Company Description

uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.

Contact Information

uniQure NV
Paasheuvelweg 25a
Amsterdam Noord-holland 1105 BP
P:(120) 240-6000
Investor Relations:
313399707536

Employees

Shareholders

Mutual fund holders53.02%
Other institutional30.20%
Individual stakeholders11.79%

Top Executives

Matt KapustaChief Executive Officer & Executive Director
Pierre CalozChief Operating Officer
Christian KlemtChief Financial Officer
Ricardo DolmetschPresident-Research & Development
Maria E. CantorChief Communications Officer